{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:05:46Z","timestamp":1759017946902,"version":"3.44.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.annder.2014.11.007","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T23:45:38Z","timestamp":1419896738000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Localisation cutan\u00e9e mammaire r\u00e9v\u00e9latrice d\u2019un lymphome T\/NK extranodal de type nasal"],"prefix":"10.1016","volume":"142","author":[{"given":"E.","family":"Fr\u00e9ling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Granel-Brocard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Serrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Barbaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Schmutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2014.11.007_bib0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hon.847","article-title":"Extranodal NK\/T-cell lymphoma: diagnosis and treatment clues","volume":"26","author":"Suzuki","year":"2008","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.annder.2014.11.007_bib0010","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.annder.2014.11.007_bib0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1440-1827.2000.01108.x","article-title":"The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists","volume":"50","year":"2000","journal-title":"Pathol Int"},{"key":"10.1016\/j.annder.2014.11.007_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.beha.2013.04.003","article-title":"International analysis of the frequency and outcomes of NK\/T-cell lymphomas","volume":"26","author":"William","year":"2013","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.annder.2014.11.007_bib0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.oraloncology.2006.03.011","article-title":"Extranodal NK\/T-cell lymphoma, nasal-type","volume":"43","author":"Al-Hakeem","year":"2007","journal-title":"Oral Oncol"},{"key":"10.1016\/j.annder.2014.11.007_bib0030","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extra-nasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"year":"2008","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","key":"10.1016\/j.annder.2014.11.007_bib0035"},{"key":"10.1016\/j.annder.2014.11.007_bib0040","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.leu.2403262","article-title":"Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK-cells","volume":"18","author":"Suzuki","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.annder.2014.11.007_bib0045","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood-2010-08-302737","article-title":"NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series","volume":"117","author":"Mansoor","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.annder.2014.11.007_bib0050","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1182\/blood.V84.8.2721.2721","article-title":"Chronic natural killer-cell lymphocytosis: a descriptive clinical study","volume":"84","author":"Tefferi","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.annder.2014.11.007_bib0055","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","article-title":"Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK-cell leukemia and extranodal NK-cell lymphoma, nasal-type","volume":"21","author":"Suzuki","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annder.2014.11.007_bib0060","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/lary.24371","article-title":"Extranodal natural killer\/T-Cell lymphoma: a population-based comparison of sinonasal and extra-nasal disease","volume":"124","author":"Vazquez","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.annder.2014.11.007_bib0065","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1007\/s12032-011-0011-0","article-title":"Prognostic factors of Chinese patients with T\/NK-cell lymphoma: a single institution study of 170 patients","volume":"29","author":"Xu","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.annder.2014.11.007_bib0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","article-title":"Extranodal NK\/T-cell lymphoma, nasal-type: a report of 73 cases at MD Anderson Cancer Center","volume":"37","author":"Li","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annder.2014.11.007_bib0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2133.2008.08922.x","article-title":"Extranodal NK\/T-cell lymphoma with cutaneous involvement: \u201cnasal\u201d vs \u201cnasal-type\u201d subgroups\u00a0\u2013\u00a0a retrospective study of 18 patients","volume":"160","author":"Choi","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2014.11.007_bib0080","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/annonc\/mdh268","article-title":"CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature","volume":"15","author":"Bekkenk","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annder.2014.11.007_bib0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood-2009-11-252957","article-title":"Cutaneous extranodal NK\/T-cell lymphoma: a clinicopathologic study of 5 patients with array-based comparative genomic hybridization","volume":"116","author":"Berti","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.annder.2014.11.007_bib0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/DAD.0b013e318230ee41","article-title":"A case of primary cutaneous extranodal natural killer\/t-cell lymphoma, nasal-type, with a 22-year indolent clinical course","volume":"34","author":"Zuriel","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.annder.2014.11.007_bib0095","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jaad.2013.11.028","article-title":"Clinicopathologic and molecular features in cutaneous extranodal natural killer\u2013\/T-cell lymphoma, nasal-type, with aggressive and indolent course","volume":"70","author":"Fried","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.11.007_bib0100","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/modpathol.3800157","article-title":"Nasal-type extranodal natural killer\/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore","volume":"17","author":"Ng","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annder.2014.11.007_bib0105","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1309\/2F39NX1AL3L54WU8","article-title":"NK-Cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype","volume":"127","author":"Hasserjian","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.annder.2014.11.007_bib0110","first-page":"91","article-title":"Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand","volume":"7","author":"Mitarnun","year":"2006","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.annder.2014.11.007_bib0115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2141.1997.752711.x","article-title":"Clonal chromosomal abnormalities as direct evidence for clonality in nasal T\/natural killer-cell lymphomas","volume":"97","author":"Tien","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annder.2014.11.007_bib0120","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1046\/j.1365-2141.1997.3223139.x","article-title":"Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK-cell lymphoma\/leukaemia","volume":"98","author":"Wong","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annder.2014.11.007_bib0125","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/annonc\/mdi037","article-title":"Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years","volume":"16","author":"Au","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annder.2014.11.007_bib0130","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor-suppressor genes in natural killer-cell malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.annder.2014.11.007_bib0135","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","article-title":"Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses","volume":"118","author":"Karube","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.annder.2014.11.007_bib0140","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2005-09-3778","article-title":"Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas","volume":"107","author":"Tam","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.annder.2014.11.007_bib0145","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.1073\/pnas.1115128108","article-title":"PRDM1 is a tumor-suppressor gene in natural killer-cell malignancies","volume":"108","author":"K\u00fc\u00e7\u00fck","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.annder.2014.11.007_bib0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.beha.2013.04.006","article-title":"Molecular underpinning of extranodal NK\/T-cell lymphoma","volume":"26","author":"Huang","year":"2013","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.annder.2014.11.007_bib0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.seminhematol.2013.11.007","article-title":"Pathogenesis and treatment of extranodal natural killer\/T-Cell lymphoma","volume":"51","author":"Suzuki","year":"2014","journal-title":"Semin Hematol"},{"key":"10.1016\/j.annder.2014.11.007_bib0160","first-page":"2028","article-title":"Molecular characterization of circulating EBV-DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients","volume":"63","author":"Chan","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.annder.2014.11.007_bib0165","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","article-title":"Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer-cell and EBV-positive lymphomas in immunocompetent patients","volume":"104","author":"Au","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.annder.2014.11.007_bib0170","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","article-title":"Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal-type","volume":"118","author":"Suzuki","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.annder.2014.11.007_bib0175","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1158\/1078-0432.CCR-12-1064","article-title":"Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal-type","volume":"18","author":"Ito","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annder.2014.11.007_bib0180","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","article-title":"Frequent expression of P-glycoprotein\/MDR1 by nasal T-cell lymphoma cells","volume":"76","author":"Yamaguchi","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.annder.2014.11.007_bib0185","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.V93.2.599","article-title":"P-glycoprotein expression on normal and abnormally expanded natural killer-cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833","volume":"93","author":"Egashira","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.annder.2014.11.007_bib0190","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","article-title":"Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan clinical oncology group study JCOG0211","volume":"27","author":"Yamaguchi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annder.2014.11.007_bib0195","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1200\/JCO.2012.45.6541","article-title":"Concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211","volume":"30","author":"Yamaguchi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annder.2014.11.007_bib0200","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-Cell lymphoma: consortium for improving survival of lymphoma study","volume":"27","author":"Kim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annder.2014.11.007_bib0205","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","article-title":"SMILE for natural killer\/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group","volume":"120","author":"Kwong","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.annder.2014.11.007_bib0210","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","article-title":"Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase 2 study","volume":"117","author":"Jaccard","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.annder.2014.11.007_bib0215","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.7314\/APJCP.2014.15.15.6275","article-title":"Efficacy and tolerance of pegaspargase-based chemotherapy in patients with nasal-type extranodal NK\/T-cell lymphoma: a pilot study","volume":"15","author":"Wen","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.annder.2014.11.007_bib0220","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10637-014-0102-9","article-title":"Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase","volume":"32","author":"Chien","year":"2014","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.annder.2014.11.007_bib0225","doi-asserted-by":"crossref","DOI":"10.1111\/nyas.12496","article-title":"Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia","author":"Salzer","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.annder.2014.11.007_bib0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2009.07802.x","article-title":"Advances in the management and monitoring of extranodal NK\/T-cell lymphoma, nasal-type","volume":"147","author":"Liang","year":"2009","journal-title":"Br J Haematol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963814012861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963814012861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:02:28Z","timestamp":1758970948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963814012861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0151963814012861"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2014.11.007","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Localisation cutan\u00e9e mammaire r\u00e9v\u00e9latrice d\u2019un lymphome T\/NK extranodal de type nasal","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2014.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}